We have lots of screening in place; that's what militaries do. It's not specifically with regard to mefloquine, but after deployment, we have an enhanced post-employment screening. We're really looking for anybody who's having difficulties of any nature after deployment—physical, neuropsychiatric. If they do have concerns, we do a thorough assessment. We look for symptomology that fits certain syndromes, and then we address that.
On May 6th, 2019. See this statement in context.